James Beeson
@beesonmalaria.bsky.social
Public Health Physician and Researcher. Malaria, maternal and child health, global health.
Here is a visual summary of the study, revealing the importance of antibody specificity in RTS,S vaccine immunity against #malaria @burnetinstitute.bsky.social
PLOS Medicine@plosmedicine.org · 3mo ago📣In a post hoc analysis of antibody responses elicited by the RTS, S/AS01 malaria vaccine, Alessia Hysa and colleagues identify candidate antibody specificities that associate with protection against #malaria in children. 🧪#MedSky plos.io/4udoUyd
Antibody fine specificity correlates with protection from malaria with the RTS,S vaccine in young African children doi.org/10.1371/jour... @burnetinstitute.bsky.social
James Beeson@beesonmalaria.bsky.social · 2mo agoNew findings reveal promising correlates of protection for the RTS,S #malaria #vaccine and new insights to inform the development of next-generation malaria vaccines. @burnetinstitute.bsky.social @acreme.bsky.social journals.plos.org/plosmedicine...
New findings reveal promising correlates of protection for the RTS,S #malaria #vaccine and new insights to inform the development of next-generation malaria vaccines. @burnetinstitute.bsky.social @acreme.bsky.social journals.plos.org/plosmedicine...
New findings reveal promising correlates of protection for the RTS,S malaria vaccine and new insights to inform the development of next-generation malaria vaccines. #malaria #vaccines @burnetinstitute.bsky.social @acreme.bsky.social doi.org/10.1371/jour...
Women’s preferences for integrated health care over time relative to coexisting health needs From our new study just published #maternalhealth #childhealth #globalhealth @cellpress.bsky.social doi.org/10.1016/j.me...
New longitudinal research from Papua New Guinea makes a compelling case for integrated maternal & infant health care in low- and middle-income countries. #MaternalHealth #GlobalHealth #WomensHealth #PublicHealth #malaria doi.org/10.1016/j.me...
New paper reveals how the human immune system fights #malaria caused by Plasmodium vivax, opening new avenues to develop #vaccines against the most widespread form of malaria. Published in @cp-immunity.bsky.social @burnetinstitute.bsky.social @wehi-research.bsky.social doi.org/10.1016/j.im...
James Beeson@beesonmalaria.bsky.social · last yr.New study shows Plasmodium falciparum evades immune attack by varying invasion ligands. Antibodies target PfRH1 & PfRH2b, but variation limits efficacy. Multi-target vaccines may be key to blocking blood-stage malaria. #Malaria #Immunology #VaccineResearch www.frontiersin.org/journals/imm...
New study shows Plasmodium falciparum evades immune attack by varying invasion ligands. Antibodies target PfRH1 & PfRH2b, but variation limits efficacy. Multi-target vaccines may be key to blocking blood-stage malaria. #Malaria #Immunology #VaccineResearch www.frontiersin.org/journals/imm...
Frontiers | Plasmodium falciparum reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion
frontiersin.org
Highly protective and long lasting #vaccines for #malaria may be crucial to make major gains and achieve elimination in the long term. #worldmalariaday
On #worldmalariaday its great to be working with wonderful people in our ACREME program to find new solutions for #malaria. @acreme.bsky.social @burnetinstitute.bsky.social
Australian Centre of Research Excellence in Malaria Elimination@acreme.bsky.social · last yr.We must increase funding, invest in proven interventions, build stronger health systems and drive forward innovative tools and strategies to accelerate progress towards malaria elimination goals. Read more from @freyafowkes.bsky.social 🦟shorturl.at/3dIDx #WorldMalariaDay
We must increase funding, invest in proven interventions, build stronger health systems and drive forward innovative tools and strategies to accelerate progress towards malaria elimination goals. Read more from @freyafowkes.bsky.social 🦟shorturl.at/3dIDx #WorldMalariaDay
🌍🦟 It's #WorldMalariaDay! Join the global fight – register now for virtual participation at 'BioMalPar XXI' and access vital research + dialogue from anywhere in the world. 🌐🧪 🔗 s.embl.org/bmp25-01-bl #EMBLMalaria #WorldMalariaDay #Malaria #MalariaConference #GlobalHealth #EndMalaria
🔧 No single tool will #EndMalaria. But when used together, the tools we have—including vaccines, medicines & bed nets—are powerful, especially as part of locally led, context-driven prevention strategies. As #WorldMalariaDay approaches, let’s invest in what works and deliver it to all 🚀 @mmv.org
In recognition of #WorldMalariaDay, GHTC's Executive Director Dr. Kristie Mikus reflects on her own experience with malaria and urges leaders and policymakers to continue to invest in innovations to address it. www.ghtcoalition.org/blog/malaria...
Malaria nearly took my life. Innovation may be what finally ends it, if we let it.
In recognition of World Malaria Day, GHTC Executive Director Dr. Kristie Mikus reflects on her own experience with malaria and urges leaders and policymakers to continue to invest in innovations to ad...
ghtcoalition.org
FROM WHO: World Malaria Day 25 April 2025 - Malaria ends with us: Reinvest, Reimagine, Reignite. A grassroots campaign to re-energize efforts at all levels to accelerate progress towards malaria elimination. www.malariaworld.org/blogs/world-... #malaria #worldmalariaday
Pleased to be involved in a great new #malaria paper. Identified an i-body (antibody-like molecule) that blocks host-cell invasion. Remarkably, i-body targeted a conserved epitope on different Plasmodium species. Are pan-species therapeutics or vaccines possible? www.nature.com/articles/s41...
A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites - Nature Communications
Apical membrane antigen-1 (AMA1) is important for Plasmodium parasite invasion, but surface polymorphisms in P. falciparum AMA1 hamper vaccine and antibody development. Here the authors identify a hum...
nature.com
Exciting new paper reporting the finding of a potent human monoclonal antibody against Plasmodium vivax #malaria. Blocks sporozoite infection of the liver, and blood stage replication, targets AMA1. www.nature.com/articles/s41...
Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages - Nature Communications
Here the authors isolate monoclonal antibodies specific for Plasmodium vivax apical membrane antigen 1, and characterize the epitope of one antibody that inhibits invasion of reticulocytes and hepatoc...
nature.com
